Unilab entered into licensing agreement with Pharex for a new drug known as "AntiCOV" Unilab will receive an amount of P1 billion if "antiCOV" received approval from Food and Drug Administration (FDA). Based on prior approval, Unilab determined that it is 80% likely that "AntiCOV" will receive approval. How much is the transaction price? 200,000,000 O 800,000,000 1,000,000,000 (bonus)